Verificando…
Traduzido automaticamente. Doses e advertências: confira o original em inglês. Ler em inglês

Chlorakris

NAFDAC Reg. No. A11-100386 · Drug

Registered with NAFDAC. Registration activeAs of 1 November 2026 · synced automatically from official sources.
Product
Chlorakris
Número NAFDAC
A11-100386
Princípio ativo
Chloramphenicol Palmitate
Dosagem
250 mg
Forma
Capsule
Tamanho da embalagem
10 x 10's (in Alu-PVC blisters)
Manufacturer
Not listed
Applicant (holder)
Krishat Pharma Industries Limited
Approved
26 May 2022
Situação
Active View on NAFDAC ↗
Registro válido até
25 May 2027
Alertas da OMS
None found
Community reports
None
Times checked
0

About the medicine: Chloramphenicol palmitate: uses, dosage and brands worldwide

What we found

  • Chlorakris is on the NAFDAC register with an active registration (A11-100386). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Chlorakris

O que diz a bula oficial. Se um médico receitou, siga a receita. Se a bula da sua caixa for diferente, vale a da sua caixa.

Advertência grave: Serious and fatal blood dyscrasias (aplastic anemia, hypoplastic anemia, thrombocytopenia and granulocytopenia) are known to occur after the administration of chloramphenicol. In addition, there have been reports of aplastic anemia attributed to chloramphenicol which later terminated in leukemia. Blood dyscrasias have occurred after both short-term and prolonged therapy with this drug. …
Children
  • Precaution should be used in therapy of premature and full-term
  • Neonates and infants to avoid “gray syndrome” toxicity
  • Due to immature metabolic processes in the neonate and infant, excessive blood levels may result from administration of the recommended dose
  • The dosage should be adjusted accordingly or, preferable, the blood concentration should be determined at appropriate intervals (see ADVERSE REACTIONS , "Gray Syndrome" )
  • See DOSAGE AND ADMINISTRATION for dosing information in the pediatric population
Older adults

Clinical studies of chloramphenicol sodium succinate did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. …

Talk to a doctor first if
  • Chloramphenicol is contraindicated in individuals with a history of previous hypersensitivity and/or toxic reaction to it
  • It must not be used in the treatment of trivial infections or where it is not indicated, as in colds, influenza, infections of the throat; or as a prophylactic agent to prevent bacterial infections
Medicines it may not mix with

Concurrent therapy with other drugs that may cause bone marrow depression should be avoided.

Warnings

PRECAUTIONS: General Repeated courses of chloramphenicol treatment should be avoided if at all possible. Treatment should not be continued longer than required to produce a cure with little or no risk or relapse of the disease. Excessive blood levels may result from administration of the recommended dose to patients with impaired liver or kidney function. The dosage should be adjusted accordingly, or preferably, the blood concentration should be determined at appropriate intervals. The use of this antibiotic, as with other antibiotics, may result in an overgrowth of nonsusceptible organisms, including fungi. …

Possíveis efeitos colaterais

Blood Dyscrasias The most serious adverse effect of chloramphenicol is bone marrow depression. Serious and fatal blood dyscrasias (aplastic anemia, hypoplastic anemia, thrombocytopenia, and granulocytopenia) are known to occur after the administration of chloramphenicol. An irreversible type of marrow depression leading to aplastic anemia with a high rate of mortality is characterized by the appearance weeks or months after therapy of bone marrow aplasia or hypoplasia. Peripherally, pancytopenia is most often observed, but in a small number of cases only one or two of the three major cell types (erythrocytes, leukocytes, platelets) may be depressed. …

Pregnancy and breastfeeding

Pregnancy Pregnancy Category C – Animal reproduction studies have not been conducted with chloramphenicol. There are no adequate and well-controlled studies to establish safety of this drug in pregnancy. It is not known whether chloramphenicol can cause fetal harm when administered to a pregnant woman. Orally administered chloramphenicol has been shown to cross the placental barrier. …

Se esquecer uma dose

Tome assim que lembrar, a menos que esteja quase na hora da próxima dose. Nesse caso, pule a dose esquecida. Nunca tome duas doses de uma vez para compensar. Confira a bula, pois alguns medicamentos são diferentes.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2024-10-10.

Label for chloramphenicol palmitate, the active ingredient registered with NAFDAC.

Check your pack of Chlorakris

Add the expiry date on your pack for a full Trust Score.

Ou tire fotos da caixa
Restam 3 verificações grátis hoje Fontes oficiais: FDA dos EUA · EMA (UE) · NAFDAC · alertas da OMS

About Chlorakris

What is in Chlorakris?

Chlorakris contains Chloramphenicol Palmitate (250 mg), as capsule, according to its NAFDAC registration record.

Is Chlorakris registered with NAFDAC?

Yes. Chlorakris is listed on the NAFDAC register under registration number A11-100386, and its registration is active as of 1 November 2026.

Has Chlorakris been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Chlorakris in our automatically synced alert list.

How can I check that my pack of Chlorakris is genuine?

Run a free authenticity scan with the NAFDAC number A11-100386, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Chlorakris? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.